# IBANDRONATE SODIUM
> **ANDA079002** · Abbreviated New Drug Application (Generic) · Sponsor: COBALT LABS INC · Approved 2011-03-15
## Drug
- **FDA Application Number:** ANDA079002
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBANDRONATE SODIUM
- **Generic name:** Ibandronate Sodium
- **Active ingredients:** IBANDRONATE SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** COBALT LABS INC
- **First approval:** 2011-03-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079002)
---
*MORVS · CC0 1.0*